Dubuque Bank & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-57
Closed -$5K – 778
2017
Q4
$5K Buy
+57
New +$4.78K ﹤0.01% 579
2016
Q1
– Sell
-1,008
Closed -$71K – 716
2015
Q4
$71K Sell
1,008
-2,721
-73% -$186K 0.02% 268
2015
Q3
$232K Sell
3,729
-10,140
-73% -$799K 0.05% 183
2015
Q2
$1.17M Buy
+13,869
New +$1.08M 0.22% 102

Other funds holding XBI

Dubuque Bank & Trust's XBI Position: Q1 2018 in Review

Dubuque Bank & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2018, closing a stake of 57 shares — an estimated $5K sold.

Dubuque Bank & Trust first reported a position in XBI in Q2 2015 and held it in 4 quarters. The position peaked at $1.17M in Q2 2015. 414 funds tracked by Wall St. Rank hold XBI as of Q1 2018.

  • Dubuque Bank & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2018 after selling out during the quarter.
  • Dubuque Bank & Trust sold 57 State Street SPDR S&P Biotech ETF shares in Q1 2018, an estimated $5K.
  • Dubuque Bank & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 4 quarters.
  • Dubuque Bank & Trust's State Street SPDR S&P Biotech ETF position peaked at $1.17M in Q2 2015.
  • 414 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2018.

Based on Dubuque Bank & Trust's 13F filing for Q1 2018, filed 10 May 2018.